CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BBI Life Sciences Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BBI Life Sciences Corp
No. 698
Xiangmin Road, Songjiang District
Phone: +86 218008201016p:+86 218008201016 Shanghai, SHA  201611  China Fax: +86 214008210268f:+86 214008210268
This company is no longer actively traded on any major stock exchange.
Business Summary
BBI Life Sciences Corporation is an investment holding company principally engaged in the development, manufacture and sales of various life science products used in scientific research, and the provision of life science related services. These products and services offered by the Company is used in the studies of life sciences including animal and plant, disease, medical diagnosis, drug development, food and agriculture industry. The Company has four business segments: deoxyribonucleic acid (DNA) synthesis products, genetic engineering services, life science research consumables as well as protein and antibody related products and services. The principal markets of the Company include the People’s Republic of China (the PRC), North America, South America, Europe and Africa.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201912/31/2019Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Executive Director QisongWang 73 10/10/2014 1/16/2014
President, Executive Director JinWang 9/26/2014 1/16/2014
Chief Executive Officer, Executive Director LuojiaWang 45 9/26/2014 9/26/2011
11 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,652 (As of 12/31/2019)
Outstanding Shares: 560,522,623 (As of 4/30/2020)
Stock Exchange: HKG
Fax Number: +86 214008210268


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023